Derya ALTAY, Özge PAMUKÇU, Ali BAYKAN, Kazım ÜZÜM, Duran ARSLAN

Aspirin-induced hepatotoxicity and anemia in children with acute rheumatic fever

Background. The aim of this study was to investigate the frequency of anemia and hepatotoxicity associated with aspirin use in patients with acute rheumatic fever. Methods. Patients with acute rheumatic fever followed at Erciyes University, Faculty of Medicine, Department of Pediatric Cardiology between 2015-2018 were reviewed retrospectively. Results. A total of 286 patients with acute rheumatic fever were analysed. Aspirin treatment was started in 53 of the 286 patients (18.5%) due to arthritis. The mean age of the patients who used aspirin was 10.7 ± 2.5 years. Aspirin-induced hepatotoxicity developed in 9 (17%) of the 53 patients. Naproxen or ibuprofen was given to these patients as an alternative to aspirin. No side effects occurred in patients receiving naproxen or ibuprofen. In addition, 30% of 53 patients were initially anemic. The mean duration of aspirin use in the hepatotoxic patients who had anemia was longer than patients without anemia (p=0.02). Conclusions. Patients with acute rheumatic fever should be closely monitored for aspirin hepatotoxicity. When aspirin hepatotoxicity develops, naproxen or ibuprofen treatment can be used safely.

PDF

___

1. Eroğlu AG. Update on diagnosis of acute rheumatic fever: 2015 Jones criteria. Turk Pediatri Ars 2016; 51: 1-7.

2. Gewitz MH, Baltimore RS, Tani LY, et al; American Heart Association Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement of the American Heart Association. Circulation 2015; 131: 1806-1818.

3. Gitlin N, Grant J. Raised serum transaminase levels in patients with rheumatic fever treated with salicylates. S Afr Med J 1977; 51: 697-698.

4. Uziel Y, Hashkes PJ, Kassem E, Padeh S, Goldman R, Wolach B. The use of naproxen in the treatment of children with rheumatic fever. J Pediatr 2000; 137: 269-271.

5. Vajro P, Maddaluno S, Veropalumbo C. Persistent hypertransaminasemia in asymptomatic children: a stepwise approach. World J Gastroenterol 2013; 19: 2740-2751.

6. Viswanathan V. Acute rheumatic fever. Indian J Rheumatol 2012; 7: 36-43.

7. Baron JA, Senn S, Voelker M, et al. Gastrointestinal adverse effects of short-term aspirin use: a meta- analysis of published rhandomized controlled trials. Drugs R D 2013; 13: 9-16.

8. Prescott LF. Hepatotoxicity of mild analgesics. Br J Clin Pharmacol 1980; 10(Suppl 2): S373-S379.

9. Meunier L, Larrey D. Recent advances in hepatotoxicity of non steroidal anti-inflammatory drugs. Ann Hepatol 2018; 17: 187-191.

10. Iancu T, Elian E. Ultrastructural changes in aspirin hepatotoxicity. Am J Clin Pathol 1976; 66: 570-575.

11. Hashkes PJ, Tauber T, Somekh E, et al; Pediatric Rheumatlogy Study Group of Israel. Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial. J Pediatr 2003; 143: 399-401.

12. Saxena A, Kumar RK, Gera RP, Radhakrishnan S, Mishra S, Ahmed Z. Working Group on Pediatric Acute Rheumatic Fever and Cardiology Chapter of Indian Academy of Pediatrics. Consensus guidelines on pediatric acute rheumatic fever and rheumatic heart disease. Indian Pediatr 2008; 45: 565-573.

13. Ralph AP, Noonan S, Boardman C, Halkon C, Currie BJ. Prescribing for people with acute rheumatic fever. Aust Prescr 2017; 40: 70-75.

14. Çetin İİ, Ekici F, Kocabaş A, et al. The efficacy and safety of naproxen in acute rheumatic fever: the comparative results of 11-year experience with acetylsalicylic acid and naproxen. Turk J Pediatr 2016; 58: 473-479.

15. Karademir S, Oğuz D, Senocak F, Ocal B, Karakurt C, Cabuk F. Tolmetin and salicylate therapy in acute rheumatic fever: comparison of clinical efficacy and side-effects. Pediatr Int 2003; 45: 676-679.

16. Uppala R, Dudiak B, Beck ME, et al. Aspirin increases mitochondrial fatty acid oxidation. Biochem Biophys Res Commun 2017; 482: 346-351.

17. Rasa M, Garcia A, Yamaga K, et al. Hematologic and hepatic anomalies in pediatric acute rheumatic fever. Ann Pediatr Res 2018; 2: 1-5.

18. Yılmaz M, Gürses D. Akut romatizmal ateş tedavisinde aspirine bağlı hepatotoksisitenin değerlendirilmesi. Pamukkale Tıp Dergisi 2020; 13: 268-274.

19. Olgun H, Bulgan M, Ceviz N, Yolcu C, Sahin IO, Laloglu F. 51st Annual Meeting of the Association for European Paediatric and Congenital Cardiology (AEPC). Incidence of aspirin-related hepatotoxicity in pediatric cases with acute rheumatic fever. Cardiol Young 2017; 27(Suppl 2): S73-S74.

20. Bitar FF, Hayek P, Obeid M, Gharzeddine W, Mikati M, Dbaibo GS. Rheumatic fever in chidren: a 15-year experience in a developing country. Pediatr Cardiol 2000; 21: 119-122.

21. Jacobs-Helber SM, Roh KH, Bailey D, et al. Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia. Blood 2003; 15: 524-531.

22. Dhur A, Galan P, Hercberg S. Effects of different degrees of iron deficiency on cytochrome P450 complex and pentose phosphate pathway dehydrogenases in the rat. J Nutr 1989; 119: 40-47.